Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults

NCT02802631 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Normal Healthy Volunteers

Interventions

DRUG: Minocin (minocycline) for Injection
OTHER: Placebo

Sponsor

Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)

Collaborators

[object Object]
[object Object]